Orthofix International NV  

(Public, NASDAQ:OFIX)   Watch this stock  
Find more results for Luke T. Faulstick
+0.22 (0.56%)
Nov 25 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 39.15 - 39.78
52 week 27.85 - 42.61
Open 39.33
Vol / Avg. 89,996.00/121,585.00
Mkt cap 744.07M
P/E     -
Div/yield     -
EPS -0.51
Shares 18.89M
Beta 0.40
Inst. own 99%
Nov 3, 2015
Q3 2015 Orthofix International NV Earnings Call - Webcast
Nov 3, 2015
Q3 2015 Orthofix International NV Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -0.78% -0.93%
Operating margin 4.09% 4.26%
EBITD margin - 9.95%
Return on average assets -0.80% -0.93%
Return on average equity -1.06% -1.26%
Employees 922 -
CDP Score - -


7 Abraham de Veerstraat, P.O. Box 840
+599-9-4658525 (Phone)
+599-9-4616978 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Orthofix International N.V. (Orthofix) is a diversified, global medical device company focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians across the world. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. Its Biologic solutions products include AlloQuent Structural Allografts, Trinity ELITE and Trinity Evolution, among others. Its Extremity Fixation solutions include Fixator and Galaxy Fixation System, among others. Its Spine Fixation solutions products include NewBridge Laminoplasty Fixation System and PILLAR PL & TL PEEK VBR System, among others. It uses independent distributors, as well as directly distributes its products in the United States, Italy, the United Kingdom, Germany, Switzerland, Austria, France, Brazil, Australia, and Puerto Rico.

Officers and directors

Ronald A. Matricaria Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Bradley R. Mason President, Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Doug Rice Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Davide Bianchi President - Global Extremity Fixation
Age: 50
Bio & Compensation  - Reuters
Jeffrey M. Schumm Chief Administrative Officer, General Counsel, Corporate Secretary
Age: 53
Bio & Compensation  - Reuters
Michael M. Finegan Chief Strategy Officer
Age: 51
Bio & Compensation  - Reuters
Luke T. Faulstick Director
Age: 51
Bio & Compensation  - Reuters
Lilly Marks Director
Bio & Compensation  - Reuters
James F. Hinrichs Independent Director
Age: 47
Bio & Compensation  - Reuters
Guy J. Jordan Ph.D. Independent Director
Age: 66
Bio & Compensation  - Reuters